371 related articles for article (PubMed ID: 36283919)
1. Long COVID: An inevitable sequela of SARS-CoV-2 infection.
Lai CC; Hsu CK; Yen MY; Lee PI; Ko WC; Hsueh PR
J Microbiol Immunol Infect; 2023 Feb; 56(1):1-9. PubMed ID: 36283919
[TBL] [Abstract][Full Text] [Related]
2. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
Rahmati M; Udeh R; Yon DK; Lee SW; Dolja-Gore X; McEVoy M; Kenna T; Jacob L; López Sánchez GF; Koyanagi A; Shin JI; Smith L
J Med Virol; 2023 Jun; 95(6):e28852. PubMed ID: 37288652
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: from an acute to chronic disease? Potential long-term health consequences.
Higgins V; Sohaei D; Diamandis EP; Prassas I
Crit Rev Clin Lab Sci; 2021 Aug; 58(5):297-310. PubMed ID: 33347790
[TBL] [Abstract][Full Text] [Related]
5. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
[TBL] [Abstract][Full Text] [Related]
6. Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection.
Savelieff MG; Feldman EL; Stino AM
Neurobiol Dis; 2022 Jun; 168():105715. PubMed ID: 35364273
[TBL] [Abstract][Full Text] [Related]
7. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. Long COVID.
Guziejko K; Tałałaj J; Czupryna P; Moniuszko-Malinowska A
Przegl Epidemiol; 2022; 76(3):287-295. PubMed ID: 36520039
[TBL] [Abstract][Full Text] [Related]
10. An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine.
Davoudi F; Miyashita S; Yoo TK; Lee PT; Foster GP
Crit Pathw Cardiol; 2022 Sep; 21(3):123-129. PubMed ID: 35994720
[TBL] [Abstract][Full Text] [Related]
11. "Long Haulers".
Lutchmansingh DD; Higuero Sevilla JP; Possick JD; Gulati M
Semin Respir Crit Care Med; 2023 Feb; 44(1):130-142. PubMed ID: 36646091
[TBL] [Abstract][Full Text] [Related]
12. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
13. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
14. Acute bone loss following SARS-CoV-2 infection in mice.
Haudenschild AK; Christiansen BA; Orr S; Ball EE; Weiss CM; Liu H; Fyhrie DP; Yik JHN; Coffey LL; Haudenschild DR
J Orthop Res; 2023 Sep; 41(9):1945-1952. PubMed ID: 36815216
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary manifestations in long COVID].
Sommer N; Schmeck B
Inn Med (Heidelb); 2022 Aug; 63(8):819-829. PubMed ID: 35925073
[TBL] [Abstract][Full Text] [Related]
16. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
17. Post-viral fatigue in COVID-19: A review of symptom assessment methods, mental, cognitive, and physical impairment.
Campos MC; Nery T; Starke AC; de Bem Alves AC; Speck AE; S Aguiar A
Neurosci Biobehav Rev; 2022 Nov; 142():104902. PubMed ID: 36202253
[TBL] [Abstract][Full Text] [Related]
18. Persistent post-COVID-19 neuromuscular symptoms.
Abrams RMC; Zhou L; Shin SC
Muscle Nerve; 2023 Oct; 68(4):350-355. PubMed ID: 37466117
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MEK signaling prevents SARS-CoV2-induced lung damage and improves the survival of infected mice.
Xie J; Klemsz MJ; Kacena MA; Sandusky G; Zhang X; Kaplan MH
J Med Virol; 2022 Dec; 94(12):6097-6102. PubMed ID: 36030555
[TBL] [Abstract][Full Text] [Related]
20. The Long Road of Long COVID: Specific Considerations for the Allergist/Immunologist.
Bellanti JA; Novak P; Faitelson Y; Bernstein JA; Castells MC
J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3335-3345. PubMed ID: 37774781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
